Severe biventricular cardiomyopathy in both current and former long-term users of anabolic–androgenic steroids
R Abdullah, A Bjørnebekk, LE Hauger… - European Journal of …, 2024 - academic.oup.com
Aims This study aims to explore the cardiovascular effects of long-term anabolic–androgenic
steroid (AAS) use in both current and former weightlifting AAS users and estimate the …
steroid (AAS) use in both current and former weightlifting AAS users and estimate the …
Long-term anabolic-androgenic steroid use is associated with left ventricular dysfunction
AL Baggish, RB Weiner, G Kanayama… - Circulation: Heart …, 2010 - Am Heart Assoc
Background—Although illicit anabolic-androgenic steroid (AAS) use is widespread, the
cardiac effects of long-term AAS use remain inadequately characterized. We compared …
cardiac effects of long-term AAS use remain inadequately characterized. We compared …
Chronic anabolic androgenic steroid administration reduces global longitudinal strain among off-cycle bodybuilders
S Hammoud, BJF van den Bemt, A Jaber… - International Journal of …, 2023 - Elsevier
Background Supra-physiologic doses of anabolic androgenic steroids (AAS) lead to multiple
cardiovascular complications. The long-term clinical effect of AAS overuse on cardiac …
cardiovascular complications. The long-term clinical effect of AAS overuse on cardiac …
Anabolic androgenic steroids induce reversible left ventricular hypertrophy and cardiac dysfunction. Echocardiography results of the HAARLEM study
Background The use of anabolic androgenic steroids (AAS) is not uncommon among
strength athletes. Several cross-sectional studies have linked AAS use to heart disease, but …
strength athletes. Several cross-sectional studies have linked AAS use to heart disease, but …
Cardiac systolic dysfunction in past illicit users of anabolic androgenic steroids
Background Illicit use of anabolic androgenic steroids (AAS) is associated with left ventricle
(LV) systolic dysfunction and increased LV mass (LVM), but whether these findings persist in …
(LV) systolic dysfunction and increased LV mass (LVM), but whether these findings persist in …
Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?
A Urhausen, T Albers, W Kindermann - Heart, 2004 - heart.bmj.com
Objective: To investigate the reversibility of adverse cardiovascular effects after chronic
abuse of anabolic androgenic steroids (AAS) in athletes. Methods: Doppler …
abuse of anabolic androgenic steroids (AAS) in athletes. Methods: Doppler …
Cardiovascular phenotype of long‐term anabolic‐androgenic steroid abusers compared with strength‐trained athletes
TS Fyksen, P Vanberg, K Gjesdal… - … journal of medicine …, 2022 - Wiley Online Library
Introduction Abuse of anabolic‐androgenic steroids (AAS) has been linked to a variety of
different cardiovascular (CV) side effects, but still the clinical effects of AAS abuse on CV risk …
different cardiovascular (CV) side effects, but still the clinical effects of AAS abuse on CV risk …
Anabolic steroid use as the possible precipitant of dilated cardiomyopathy
PC Ferrera, DL Putnam, VP Verdile - Cardiology, 1997 - karger.com
Anabolic-androgenic steroid (AAS) use is common among young males, including
adolescents. There have been several anecdotal reports of severe cardiovascular events in …
adolescents. There have been several anecdotal reports of severe cardiovascular events in …
Anabolics and cardiomyopathy in a bodybuilder: case report and literature review
BACKGROUND: Athletes use androgenic-anabolic steroids to increase strength and muscle
mass. Several case reports suggest that it may lead to dilated cardiomyopathy. METHODS …
mass. Several case reports suggest that it may lead to dilated cardiomyopathy. METHODS …
[HTML][HTML] Anabolic androgenic steroids and cardiomyopathy: an update
Anabolic androgenic steroids (AAS) include endogenously produced androgens like
testosterone and their synthetic derivatives. Their influence on multiple metabolic pathways …
testosterone and their synthetic derivatives. Their influence on multiple metabolic pathways …